ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: SA-PO396

Hyperfiltration in Obese Diabetic BTBRob/ob Mice Can Be Measured Transcutaneously

Session Information

Category: Diabetic Kidney Disease

  • 701 Diabetic Kidney Disease: Basic


  • Hettler, Steffen Andreas, Universitat Heidelberg, Mannheim, Baden-Württemberg, Germany
  • Pastene, Diego O., Universitat Heidelberg, Mannheim, Baden-Württemberg, Germany
  • Yard, Benito, Universitat Heidelberg, Mannheim, Baden-Württemberg, Germany
  • Krämer, Bernhard K., Universitat Heidelberg, Mannheim, Baden-Württemberg, Germany

Transcutaneous assessment of glomerular filtration rate (tGFR) has only been validated in lean mice. At 24 weeks obese diabetic mice display vasodilation of the afferent glomerular arteriole and increased glomerular size, yet do not differ in tGFR values from lean mice. Hence, we questioned if hyperfiltration can be assessed transcutaneously in obese diabetic mice.


We measured tGFR and FITC-sinistrin plasma clearance simultaneously in obese diabetic BTBRob/ob and lean non-diabetic BTBRwt/- mice at week 12. At week 24 we assessed tGFR again and used tissue clearing and light sheet microscopy to assess glomerular size and vasodilation of the afferent arteriole in mice that were perfused with an infrared fluorescent dye.


While at week 12 tGFR significantly differed between the groups with a faster clearance in the diabetic BTBRob/ob mice (both t1/2 of FITC-sinistrin (p=0.0081) and calculated GFR (p=0.0069)), no difference was found between diabetic and non-diabetic mice in tGFR at 24 weeks. In line with the increased tGFR, also FITC-sinistrin plasma clearance was significantly increased at week 12 in BTBRob/ob mice (p=0.0140). At week 24 the diameter of afferent arterioles were significantly larger in BTBRob/ob vs. BTBRwt/- mice (p=0.0007) and associated with increased glomerular size (p=0.0136).


The results indicate that hyperfiltration can be detected in diabetic mice by tGFR early in the course of disease. In keeping with the findings that no difference in tGFR was found at 24 weeks despite morphological parameters that indicate hyperfiltration, our data might be explained by progressive loss of functional nephrons later in the disease. Accordingly, this will reduce total glomerular filtration while increased glomerular pressure and dilation of the afferent glomerular arterioles (and presumably single nephron glomerular hyperfiltration) remain in nonsclerotic nephrons.


  • Government Support – Non-U.S.